BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16798287)

  • 21. Prospective follow-up of menstrual disorders in adolescence and prognostic factors.
    Wiksten-Almströmer M; Hirschberg AL; Hagenfeldt K
    Acta Obstet Gynecol Scand; 2008; 87(11):1162-8. PubMed ID: 18956264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polycystic ovary syndrome. A diagnostic challenge.
    Lewis V
    Obstet Gynecol Clin North Am; 2001 Mar; 28(1):1-20. PubMed ID: 11292997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evidence-based therapy of polycystic ovarian syndrome].
    Gődény S; Csenteri OK
    Orv Hetil; 2015 Nov; 156(45):1803-15. PubMed ID: 26551444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical presentation of PCOS following development of an insulinoma: case report.
    Murray RD; Davison RM; Russell RC; Conway GS
    Hum Reprod; 2000 Jan; 15(1):86-8. PubMed ID: 10611194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosing polycystic ovary syndrome in adolescent girls].
    Drosdzol-Cop A; Sidło-Stawowy A; Sajdak D; Skrzypulec-Plinta V
    Ginekol Pol; 2014 Feb; 85(2):145-8. PubMed ID: 24745161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
    Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
    Fertil Steril; 2009 Feb; 91(2):456-88. PubMed ID: 18950759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents.
    Hillard PJ
    Endocrinol Metab Clin North Am; 2005 Sep; 34(3):707-23, x. PubMed ID: 16085167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls.
    Lanzo E; Monge M; Trent M
    Pediatr Ann; 2015 Sep; 44(9):e223-30. PubMed ID: 26431241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and Treatment of Polycystic Ovary Syndrome.
    Huddleston HG; Dokras A
    JAMA; 2022 Jan; 327(3):274-275. PubMed ID: 35040896
    [No Abstract]   [Full Text] [Related]  

  • 31. [Influence of weight and distribution of adipose tissue in functional hyperandrogenism].
    Pasquali R; Vicennati V; Gambineri A
    Contracept Fertil Sex; 1998 May; 26(5):372-5. PubMed ID: 9648381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic difficulties of polycystic ovarian syndrome in adolescent girls].
    Ságodi L; Barkai L
    Orv Hetil; 2013 Jan; 154(4):136-42. PubMed ID: 23335723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovary syndrome and female reproduction.
    Elghblawi E
    Br J Nurs; 2007 Oct 11-24; 16(18):1118-21. PubMed ID: 18073681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Has oligomenorrhea a pathological meaning? The importance of this symptom in internal medicine].
    Devoto E; Aravena L; Gaete X
    Rev Med Chil; 1998 Aug; 126(8):943-51. PubMed ID: 9830746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study.
    Kent SC; Gnatuk CL; Kunselman AR; Demers LM; Lee PA; Legro RS
    J Clin Endocrinol Metab; 2008 May; 93(5):1662-9. PubMed ID: 18270257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Polycystic ovary syndrome].
    Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):298-301. PubMed ID: 10804375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset.
    Ibáñez L; de Zegher F; Potau N
    J Endocrinol Invest; 1998 Oct; 21(9):558-66. PubMed ID: 9856410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary amenorrhea as a manifestation of polycystic ovarian syndrome in adolescents: a unique subgroup?
    Rachmiel M; Kives S; Atenafu E; Hamilton J
    Arch Pediatr Adolesc Med; 2008 Jun; 162(6):521-5. PubMed ID: 18524741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of bone mineral density in normal weight and obese adolescents with polycystic ovary syndrome.
    To WW; Wong MW
    J Pediatr Adolesc Gynecol; 2012 Aug; 25(4):248-53. PubMed ID: 22840935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.